HOME Top Market Reports Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022

Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022

By: marketsandmarkets.com
Publishing Date: May 2017
Report Code: MD 5243

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for this market include the large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices.

The report provides an overall understanding of the market. In this report, the market is segmented on the basis of type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Among these type segments, the passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. The access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surgery. The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

Geographic analysis reveals that the North American segment is expected to account for the largest share of the market in 2017, owing to the increasing prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and the increasing number of research and clinical trials for vascular closure devices.

The major players in this market are Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), and  Cardiva Medical Inc. (U.S.).

Target Audience for this Report:

  • Vendors/service providers
  • Research institutes
  • Contract research organizations (CROs)
  • Contract manufacturing organizations (CMOs)
  • Interventional cardiology vascular device manufacturers
  • Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
  • Niche companies manufacturing novel vascular closure devices
  • Research and consulting firms

Scope of the Report

To know about the assumptions considered for the study, download the pdf brochure

This research report categorizes the global vascular closure devices market into the following segments and subsegments:

Vascular Closure Devices Market, by Type

  • Passive Approximators
  • Collagen Plugs
  • Sealant- or Gel-based Devices
  • Compression-assist Devices
  • Active Approximators
  • Suture-based Devices
  • Clip-based Devices
  • External Hemostatic Devices

Vascular Closure Devices Market, by Access

  • Femoral
  • Radial

Vascular Closure Devices Market, by Procedure

  • Interventional Cardiology
  • Interventional Radiology/Vascular Surgery

Vascular Closure Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe (RoE)
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the rest of Europe segment into France, Finland, Sweden, and Switzerland

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions of the Study

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 29)
    4.1 Vascular Closure Devices: Market Overview
    4.2 Geographic Analysis: Vascular Closure Devices Market, By Type (2017)
    4.3 Market, By Access, 2017 vs 2022
    4.4 Market, By Procedure, 2017 vs 2022
    4.5 Geographic Snapshot of the Vascular Closure Devices Market

5 Market Overview (Page No. - 33)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Large Number of Approvals for Vascular Closure Devices
                    5.2.1.2 High Prevalence of Cardiovascular Diseases
                    5.2.1.3 Increasing Prevalence of Obesity
                    5.2.1.4 Increasing Focus of Market Players on Large-Bore Vascular Closure Devices
           5.2.2 Restraints
                    5.2.2.1 Increasing Preference for Interventional Procedures Using Radial Artery Access
                    5.2.2.2 High Cost of Vascular Closure Devices
                    5.2.2.3 Product Recalls and Failures
           5.2.3 Opportunity
                    5.2.3.1 Emerging Markets Providing Growth Opportunities for Market Players
           5.2.4 Challenges
                    5.2.4.1 Need for Highly Skilled Professionals
                    5.2.4.2 Risks Associated With Vascular Closure Devices

6 Global Vascular Closure Devices Market, By Type (Page No. - 39)
    6.1 Introduction
    6.2 Passive Approximators
           6.2.1 Collagen Plugs
           6.2.2 Sealant Or Gel-Based Devices
           6.2.3 Compression Assist Devices
    6.3 Active Approximators
           6.3.1 Suture-Based Devices
           6.3.2 Clip-Based Devices
    6.4 External Hemostatic Devices

7 Global Vascular Closure Devices Market, By Access (Page No. - 48)
    7.1 Introduction
    7.2 Femoral Access
    7.3 Radial Access

8 Global Vascular Closure Devices Market, By Procedure (Page No. - 53)
    8.1 Introduction
    8.2 Interventional Cardiology
    8.3 Interventional Radiology/Vascular Surgery

9 Global Vascular Closure Devices Market, By Region (Page No. - 57)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
                    9.2.1.1 Rising Prevalence of Cardiovascular Diseases
                    9.2.1.2 Growing Trend of One-Day Surgeries for Vascular Procedures
                    9.2.1.3 Increase in Research and Clinical Trials for Vascular Closure Devices
                    9.2.1.4 Increasing Number of Conferences, Meetings, Symposia, and Workshops
           9.2.2 Canada
                    9.2.2.1 Increasing Number of Cardiac Arrest Cases
                    9.2.2.2 Long Waiting Times for Cardiac Surgery Likely to Encourage the Adoption of Minimally Invasive Procedures
    9.3 Europe
           9.3.1 Increasing Focus of Market Players in the European Region
           9.3.2 E-3
                    9.3.2.1 Increasing Number of Research Studies on Vascular Closure Devices in Germany
                    9.3.2.2 Rising Prevalence of CVDS in Germany
                    9.3.2.3 Increase in the Number of Radial Access Procedures in France and the U.K.
                    9.3.2.4 Growth in the Aging and Obese Populations in the U.K.
           9.3.3 RoE
    9.4 Asia-Pacific
           9.4.1 Rapid Growth in the Aging Population in Japan & China
           9.4.2 Cost—A Major Concern for Interventional Procedures in India
           9.4.3 Healthcare Reforms, Government Initiatives, and Investments in China and Japan
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 85)
     10.1 Introduction
     10.2 Vendor Dive Overview
             10.2.1 Vanguards
             10.2.2 Innovators
             10.2.3 Emerging Players
             10.2.4 Dynamic Players
     10.3 Competitive Benchmarking
             10.3.1 Analysis of the Product Portfolio of Major Players in the Market (23 Companies)
             10.3.2 Business Strategies Adopted By Major Players in the Market (23 Companies)

*Top 23 Companies Analyzed for This Study are - Tz Medical, Inc. (U.S.), Vasorum Ltd. (Ireland), Inseal Medical Ltd. (Israel), Morris Innovative Inc. (U.S.), Essential Medical Inc. (U.S.), Arstasis Inc. (U.S.), Tricol Medical Inc. (U.S.), Marine Polymer Technologies (U.S.), Hemostasis LLC (U.S.), Chitogen Inc. (U.S.), Endocor GmbH (Germany), Transluminal Technologies LLC (U.S.), Hemoband Corporation (U.S.), Vascualr Closure Systems Inc. (U.S.), Advanced Vascular Dynamics (U.S.), Scion Biomedical (U.S.), Terumo Corporation (Japan), Abbott Laboratories (U.S.), Cardinal Health, Inc. (U.S.), Cardiva Medical, Inc.(U.S.), Medtronic PLC (Ireland), Merit Medical Systems Inc. (U.S.), Vivasure Medical Ltd. (Ireland)

11 Company Profiles (Page No. - 89)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Terumo Corporation
     11.2 Abbott Laboratories
     11.3 Cardinal Health, Inc. (Cordis)
     11.4 Cardiva Medical, Inc.
     11.5 Medtronic PLC 
     11.6 Morris Innovative, Inc.
     11.7 Essential Medical, Inc.
     11.8 Merit Medical Systems, Inc.
     11.9 Vasorum Ltd.
     11.10 TZ Medical, Inc.
     11.11 Vivasure Medical Ltd.
     11.12 Inseal Medical Ltd.
     11.13 Tricol Biomedical, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 120)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (61 Tables)

Table 1 Global Vascular Closure Devices Market, By Type, 2015–2022 (USD Million)
Table 2 Market for Passive Approximators, By Region, 2015–2022 (USD Million)
Table 3 Market for Passive Approximators, By Type, 2015–2022 (USD Million)
Table 4 Collagen Plugs Market, By Region, 2015–2022 (USD Million)
Table 5 Sealant Or Gel-Based Devices Market, By Region, 2015–2022 (USD Million)
Table 6 Compression Assist Devices Market, By Region, 2015–2022 (USD Million)
Table 7 Market for Active Approximators, By Region, 2015–2022 (USD Million)
Table 8 Market for Active Approximators, By Type, 2015–2022 (USD Million)
Table 9 Suture-Based Devices Market Size, By Region, 2015–2022 (USD Million)
Table 10 Clip-Based Devices Market Size, By Region, 2015–2022 (USD Million)
Table 11 Vascular Closure Devices Market for External Hemostatic Devices, By Region, 2015–2022 (USD Million)
Table 12 Market Size, By Access, 2015–2022 (USD Million)
Table 13 Market Size for Femoral Access, By Region, 2015–2022 (USD Million)
Table 14 Market Size for Radial Access, By Region, 2015–2022 (USD Million)
Table 15 Market Size, By Procedure, 2015–2022 (USD Million)
Table 16 Market Size for Interventional Cardiology, By Region, 2015–2022 (USD Million)
Table 17 Market Size for Interventional Radiology/Vascular Surgery, By Region, 2015–2022 (USD Million)
Table 18 Market Size, By Region, 2015-2022 (USD Million)
Table 19 North America: Vascular Closure Devices Market Size, By Country, 2015-2022 (USD Million)
Table 20 North America: Market Size, By Type, 2015-2022 (USD Million)
Table 21 North America: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 22 North America: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 23 North America: Market Size, By Access, 2015-2022 (USD Million)
Table 24 North America: Market Size, By Procedure, 2015-2022 (USD Million)
Table 25 Indicative List of Recent Conferences/Meetings/Symposia/Workshops Held in the U.S.
Table 26 U.S.: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 27 U.S.: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 28 U.S.: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 29 U.S.: Market Size, By Access, 2015-2022 (USD Million)
Table 30 U.S.: Market Size, By Procedure, 2015-2022 (USD Million)
Table 31 Canada: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 32 Canada: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 33 Canada: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 34 Canada: Market Size, By Access, 2015-2022 (USD Million)
Table 35 Canada: Market Size, By Procedure, 2015-2022 (USD Million)
Table 36 Europe: Vascular Closure Devices Market Size, By Region, 2015-2022 (USD Million)
Table 37 Europe: Market Size, By Type, 2015-2022 (USD Million)
Table 38 Europe: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 39 Europe: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 40 Europe: Market Size, By Access, 2015-2022 (USD Million)
Table 41 Europe: Market Size, By Procedure, 2015-2022 (USD Million)
Table 42 E-3: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 43 E-3: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 44 E-3: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 45 E-3: Market Size, By Access, 2015-2022 (USD Million)
Table 46 E-3: Market Size, By Procedure, 2015-2022 (USD Million)
Table 47 RoE: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 48 RoE: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 49 RoE: Vascular Closure Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 50 RoE: Market Size, By Access, 2015-2022 (USD Million)
Table 51 RoE: Market Size, By Procedure, 2015-2022 (USD Million)
Table 52 Asia-Pacific: Vascular Closure Devices Market Size, By Type, 2015–2022 (USD Million)
Table 53 Asia-Pacific: Passive Approximators Market Size, By Type, 2015–2022 (USD Million)
Table 54 Asia-Pacific: Active Approximators Market Size, By Type, 2015–2022 (USD Million)
Table 55 Asia-Pacific: Market Size, By Access, 2015–2022 (USD Million)
Table 56 Asia-Pacific: Market Size, By Procedure, 2015–2022 (USD Million)
Table 57 RoW: Vascular Closure Devices Market Size, By Type, 2015–2022 (USD Million)
Table 58 RoW: Passive Approximators Market Size, By Type, 2015–2022 (USD Million)
Table 59 RoW: Active Approximators Market Size, By Type, 2015–2022 (USD Million)
Table 60 RoW: Market Size, By Access, 2015–2022 (USD Million)
Table 61 RoW: Market Size, By Procedure, 2015–2022 (USD Million)
 
 
List of Figures (30 Figures)
 
Figure 1 Research Methodology: Global Vascular Closure Devices
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Research Design: Global Vascular Closure Devices
Figure 6 Data Triangulation Methodology
Figure 7 Global Vascular Closure Devices Market, By Type (2017)
Figure 8 Global Market Size, By Access, 2017 vs 2022 (USD Million)
Figure 9 Global Market, By Procedure, 2017 vs 2022 (USD Million)
Figure 10 Geographical Snapshot of the Market
Figure 11 Rising Prevalence of Cardiovascular Diseases & Increasing Number of Regulatory Approvals are Major Factors Driving the Growth of the Market
Figure 12 Passive Approximators Segment to Account for the Largest Market Share in 2017
Figure 13 Femoral Access Segment Will Continue to Dominate the Vascular Closure Devices Market in 2022
Figure 14 Interventional Cardiology Segment to Account for the Largest Market Share in 2017
Figure 15 North America to Register the Highest CAGR in the Forecast Period
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Passive Approximators to Command the Largest Share and Register the Highest CAGR in the Global Vascular Closure Devices Market
Figure 18 Femoral Access Segment to Account for the Largest Share of the Vascular Closure Devices Market, By Access, in 2017
Figure 19 Interventional Cardiology Segment to Account for the Largest Share of the Market, By Procedure, in 2017
Figure 20 North America to Dominate the Market in 2017
Figure 21 North America: Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia-Pacific: Market Snapshot
Figure 24 RoW: Market Snapshot
Figure 25 MnM Dive - Vendor Comparison Chart
Figure 26 Terumo Corporation: Company Snapshot (2015)
Figure 27 Abbott Laboratories: Company Snapshot (2016)
Figure 28 Cardinal Health, Inc. Company Snapshot (2016)
Figure 29 Medtronic PLC: Company Snapshot (2016)
Figure 30 Merit Medical Systems, Inc.: Company Snapshot (2015)

The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for the market include a large number of approvals for vascular closure devices, increasing focus of market players on large-bore vascular closure devices, the high prevalence of cardiovascular diseases, and high prevalence of obesity. On the other hand, the high cost of vascular closure devices, product recalls and failures, and increasing preference for interventional procedures using radial artery access are limiting the growth of the global market to a certain extent.

In this report, the market has been segmented based on type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Passive approximators are expected to account for the largest share of the vascular closure devices market in 2017. Passive approximators are the most widely used vascular closure devices in the market owing to the wide range of advantages associated with them, including increased safety and fewer complications than manual procedures.

The access segment includes femoral access and radial access. The femoral access segment is estimated to account for the largest share of the market in 2017 owing to the widespread preference for this access route among cardiologists and physicians during interventional procedures as well as the fewer complications involved during arterial access.

The procedures segment of the vascular closure devices market includes interventional cardiology and interventional radiology/vascular surgery. The interventional cardiology segment is expected to hold the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases and increasing obese population across the globe.

The geographic segments in this report include North America, Europe, Asia-Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and increasing research and clinical trials for vascular closure devices.

Vascular Closure Device Market

The major players in this market include Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), Cardiva Medical Inc. (U.S.), Morris Innovative, Inc. (U.S.), Medtronic plc (Ireland), Essential Medical, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), TZ Medical, Inc. (U.S.), and Vasorum Ltd. (Ireland).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo